F-1/A: Australian Oilseeds: Financials, Nasdaq, Growth Strategy

Australian Oilseeds Holdings Limited files an amended registration statement detailing financial performance, Nasdaq listing compliance, and strategic growth initiatives for its non-GMO oilseed business.

Summary

• The company focuses on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds, operating the largest cold-pressing oil plant in Australia with a capacity of over 70,000 metric tons per annum.
• The Business Combination with EDOC Acquisition Corp. was consummated on March 21, 2024, and the company's Ordinary Shares and Warrants commenced trading on Nasdaq under COOT and COOTW on March 22, 2024.
• Sales revenue increased by AUD$8 million (23.64%) to AUD$41.7 million for the fiscal year ended June 30, 2025, compared to AUD$33.7 million in FY2024.
• Cost of sales increased significantly by AUD$10.4 million (37.5%) to AUD$38.2 million for FY2025, from AUD$27.8 million in FY2024, leading to a 41.48% decrease in gross profit to AUD$3.46 million.
• The company reported a net loss of AUD$1,462,610 for FY2025, a substantial improvement from the AUD$21,230,681 loss in FY2024, which included a large recapitalization expense.
• A net current liability position of AUD$13,056,107 was recorded for FY2025, worsening from AUD$6,965,530 in FY2024.
• Net cash inflows from operating activities were AUD$966,511 for FY2025, a positive shift from net cash outflows of AUD$2,184,930 in FY2024.
• The company is classified as an emerging growth company and a controlled company under Nasdaq rules, allowing for certain reduced disclosure and corporate governance requirements.
• Substantial doubt exists about the company's ability to continue as a going concern, dependent on generating sufficient cash from operations and securing additional funding.
• The company is highly dependent on a small group of customers (top five customers accounted for 62.4% of sales in FY2025) and local farmers for oilseed supply.

Sentiment

Score: 4

Explanation: While revenue growth and strategic initiatives are positive, the significant decline in gross profit, worsening net current liability, ongoing net losses, and substantial doubt about going concern raise serious concerns about financial health and operational efficiency. The reliance on future capital raises and the past-due promissory notes further dampen sentiment.

Positives

• Sales revenue increased by 23.64% to AUD$41.7 million in FY2025, demonstrating top-line growth.
• Retail oils revenue saw a significant increase of AUD$7.3 million (58.4%) in FY2025, driven by supply contracts with major Australian supermarket chains like Costco, Woolworths, and Coles, and the development of three new SKUs.
• High protein meals revenue grew by AUD$1.68 million (18.4%) in FY2025, attributed to increased market awareness of the company's high-quality, chemical-free products.
• The company successfully regained compliance with Nasdaq's minimum bid price requirement and the shareholders' equity rule, transferring its listing to The Nasdaq Capital Market.
• The business combination with EDOC Acquisition Corp. was consummated on March 21, 2024, establishing the company as a publicly traded entity.
• Strategic plans include expanding the existing Cootamundra facility and constructing a new, larger multi-seed crushing plant in Queensland to become the largest cold-pressed producer in the Oceanic/APAC region.
• The company is committed to sustainable, chemical-free, non-GMO products and regenerative farming practices, aligning with growing consumer demand for healthy and environmentally friendly options.
• Partial adoption of renewable solar energy at its Cootamundra facility, with a goal to become a carbon-neutral plant, supports its UN Sustainable Development Goals.
• Net cash flows from operating activities turned positive in FY2025, reaching AUD$966,511, compared to outflows in the prior year.

Negatives

• Gross profit decreased by 41.48% to AUD$3.46 million in FY2025, despite increased revenue, indicating significant pressure on profit margins.
• Cost of sales increased disproportionately by 37.5% in FY2025, primarily due to higher input costs for manufacturing (raw material, packing, labor) without a corresponding increase in sales prices.
• The company reported a net loss of AUD$1,462,610 for FY2025, continuing a history of losses.
• The net current liability position worsened significantly to AUD$13,056,107 in FY2025 from AUD$6,965,530 in FY2024.
• Substantial doubt exists about the company's ability to continue as a going concern, as highlighted by the auditors.
• Finance expenses increased by 74.21% to AUD$1,456,065 in FY2025, driven by the utilization of trade facilities and interest accrual on promissory notes.
• The company has unpaid legacy costs of AUD$2,773,492 and promissory notes to American Physicians LLC totaling AUD$1,538,322 as of June 30, 2025, with some promissory notes being past due.
• High dependence on a small group of customers, with the top five customers accounting for 62.4% of total sales in FY2025, poses a concentration risk.
• Reliance on a concentration of certain suppliers for the bulk of its oilseeds creates supply chain vulnerability.

Risks

• Stock price volatility and potential delisting from Nasdaq if minimum listing requirements are not maintained, as evidenced by past non-compliance notices.
• Principal shareholders will continue to have significant influence over the election of the board of directors and approval of significant corporate actions, including any sale of the company.
• The company lacks product and business diversification, making its future revenues and earnings highly susceptible to fluctuations within the agricultural industry.
• Dependence on contracts with local and regional farmers for oilseeds, with the loss or decline in quality of these contracts potentially having a material adverse effect on business, financial condition, and revenues.
• Exposure to global, federal, state, and local regulations, including changes to trade restrictions, food safety, sustainability requirements, and environmental laws, which could materially and adversely affect operations.
• Operations are inherently subject to changing conditions that can affect profitability, such as decreased product sales, price changes due to competitive factors, and increases in oilseed costs.
• Disruptions in water and power supply may adversely affect the company's and its suppliers' operations, particularly given Australia's susceptibility to drought and extreme weather.
• Revenue may not achieve budget in FY2026 due to capital expenditures for facility expansion and the need to manage cash flows towards payment of legacy costs.
• Failure to effectively promote the brand, especially its GMO-free cold-pressed vegetable oils, could materially and adversely affect business, financial condition, and results of operations.
• Inability to hire and retain qualified personnel to support growth could adversely affect the ability to improve products and implement business objectives.
• The retail price of products may be subject to control by government authorities, potentially reducing revenue and profitability.
• Adverse publicity associated with products, raw materials, or top suppliers and customers could harm the company's reputation, financial condition, and operating results.
• Inability to develop new products could adversely affect business and financial condition.
• Business operations and international expansion are subject to geopolitical risks, including supply chain disruptions and inflation.
• Management has limited experience in operating a public company, which could lead to increased expenses and administrative burdens.
• The business model is capital-intensive, and the inability to raise additional capital on attractive terms could be dilutive to shareholders and materially affect operations and prospects.
• Risk of product contamination leading to product liability claims and recalls, despite insurance coverage.
• Competition from more established companies with significantly greater financial, technical, and marketing resources.
• Warrants may be redeemed prior to their exercise at a time that is disadvantageous to warrant holders.
• Potential for the company to be treated as a Passive Foreign Investment Company (PFIC) for U.S. federal income tax purposes, leading to adverse tax consequences for U.S. Holders.

Future Outlook

The company intends to address increased global demand for sustainable premium cold-pressed and non-GMO products by expanding its existing cold-pressing capacity from 33,000 metric tons to 70,000 metric tons per annum. It plans to build an additional larger multi-seed crushing plant in Queensland to become the largest cold-pressed producer in the Oceanic/APAC region and aims to achieve carbon neutrality. The company expects to need to raise additional funds through equity, debt, or credit facilities to fund ongoing costs, accelerated expenses, and new strategic investments, acknowledging that revenue may not achieve budget in FY2026 due to capital expenditure for facility expansion and managing legacy payments.

Management Comments

• "The Company believes that transitioning from a fossil fuel economy to a renewable and chemical free economy is the solution to many health problems the world is facing presently."
• "The Company is committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils to customers globally."
• "Management has considered and determined that there will not be a material increase in capital expenditures or operating costs associated with climate-related matters, including costs and expenditures incurred to mitigate the physical effects of climate change or incurred in connection with any plans they may have to reduce emissions or their reliance on carbon-based energy."
• "The Company plans to maintain this minimum equity value by converting additional debt and increasing revenues." (Regarding Nasdaq equity compliance)
• "The Company believes its relationship with its employees and contractors is cooperative and its employees and contractors share the same goals as management to industrialize oilseeds, making the products available worldwide."

Industry Context

The company operates within the agricultural and food processing industry, specializing in edible oils and protein meals. Its strategy is well-aligned with the growing global demand for sustainable, chemical-free, and non-GMO food products, reflecting broader health and environmental trends. Australia's significant role in canola seed production and its proximity to the rapidly expanding Asia-Pacific consumer export markets provide a strategic advantage. The company's expansion into plant-based meats and proteins also positions it within a growing segment of the food industry driven by consumer preferences for alternative protein sources. However, it faces competition from more established players with potentially greater resources.

Comparison to Industry Standards

• The company has grown to be the largest cold pressing oil plant in Australia over the past 20+ years, specializing in GMO-free conventional and organic oilseeds.
• Australian oilseed production, due to its relative proximity and high-quality output, is well-placed to supply the rapidly expanding consumer export markets of the Asia-Pacific and satisfy increased domestic demands.
• The company processes and sells high-quality protein meal for the agricultural market and is leveraging this by-product to expand into the plant-based meats and proteins markets, indicating a forward-looking approach to market trends.
• Its cold-pressing methods are highlighted as safer due to the avoidance of harmful solvents like hexane and petroleum ether, differentiating its product quality.
• The company's Cootamundra facility was the first oil processing plant in Australia to partially adopt renewable solar energy, demonstrating an early commitment to sustainability and aiming for carbon neutrality.

Management Changes

Corporate Governance

Legal Proceedings

• Not currently a party to any legal proceedings, the outcome of which, if determined adversely to the company, would individually or in the aggregate have a material adverse effect on its business or financial condition.

Related Party Transactions

• Purchases of seed, oils, sales of meals, other sales, management fees, and leases with Energreen Nutrition Australia Pty Ltd., a company controlled by Gary Seaton (Co-CEO and Chairman).
• Purchases of oils from Soon Soon Oilmills Sdn Bhd., in which Gary Seaton holds a 20% share.
• Other sales and leases with Sunmania Pty Ltd.
• Related party loans payable to Energreen Nutrition Australia Pty Ltd. (AUD$6,317,259 total principal as of June 30, 2025), CQ Oilseeds Pty Ltd. (AUD$59,371 total principal), and Sunmania Pty Ltd. (AUD$192,000 total principal).
• Related party loan receivable from Energreen Nutrition Australia Pty Ltd. of AUD$633,733 as of June 30, 2025.
• Trade payables to Energreen Nutrition Australia Pty Ltd. (AUD$5,563,563), Soon Soon Oilmills (AUD$153,105), and Sunmania Pty Ltd. (AUD$38,500) as of June 30, 2025.
• Trade receivables from Energreen Nutrition Australia Pty Ltd. (AUD$30,040) and Sunmania Pty Ltd. (AUD$14,346) as of June 30, 2025.
• A related party loan amounting to AUD$4,998,512 owed to JSKS Enterprises Pty Ltd. (trustee of Gary Seaton Family Trust) was converted into equity shares during the year ended June 30, 2025.
• Promissory notes were issued to American Physicians, LLC (shareholders from the Sponsor of EDOC) on March 21, 2024, in principal amounts of USD$450,000 (First Promissory Note, past due) and USD$500,000 (Second Promissory Note, with payments due June 21, 2025, September 21, 2025, and December 21, 2025).
• Arena (PIPE) lodged an event of default against an Escrow account with American Physicians (AP) and withdrew USD$1 million, a non-adjusting event after the reporting period.

Stakeholder Impact

• Shareholders face potential dilution from future capital raises, stock price volatility, and must rely on price appreciation for investment return as no dividends are expected in the foreseeable future. Principal shareholders retain significant influence over corporate decisions.
• Employees may benefit from growth opportunities but the company's ability to attract and retain qualified personnel is crucial for expansion.
• Customers, particularly major supermarkets, benefit from increased product supply and new SKU offerings, but the company's high customer concentration poses a risk if key relationships are lost.
• Suppliers, especially local and regional farmers, are critical to the company's operations, and the dependence on these contracts creates mutual reliance.
• Creditors, including Commonwealth Bank of Australia and PIPE investors, are essential for the company's liquidity and going concern status, with some promissory notes currently past due.

Next Steps

• Expand existing cold-pressing capacity from 33,000 metric tons to 70,000 metric tons per annum.
• Build an additional larger multi-seed crushing plant in Queensland to become the largest cold-pressed producer in the Oceanic/APAC region.
• Launch additional product lines and increase production to meet demand and reach revenue goals while maintaining quality and sustainability.
• Maintain minimum equity value by converting additional debt and increasing revenues to ensure continued Nasdaq compliance.
• Lodge the registration statement for the US$50 million Equity Line Of Credit (ELOC).
• Address past-due promissory notes to American Physicians, LLC.
• Continue to pay legacy cost commitments.

Key Dates

Recommendation

The company demonstrates promising revenue growth in key segments like retail oils and high protein meals, and has successfully navigated Nasdaq compliance issues, indicating operational resilience. Its strategic focus on sustainable, non-GMO products aligns with strong market trends. However, the significant decline in gross profit margins, worsening net current liability position, and ongoing net losses raise serious concerns about operational efficiency and financial stability. The 'going concern' doubt and reliance on future capital raises, coupled with past-due promissory notes, introduce substantial risk. A 'hold' recommendation is appropriate as the company is in a transitional phase with both growth potential and significant financial challenges that require careful monitoring. Investors should await clearer signs of sustained profitability and improved financial health before considering further investment, while existing investors should monitor closely for execution on strategic plans and resolution of liquidity concerns.

Keywords

Oilseeds, Cold-pressed oil, Non-GMO, Sustainable agriculture, Food-grade oils, Protein meals, Australia, Nasdaq, SEC filing, Financial results, Corporate governance, Risk factors, Capital raise, Emerging growth company, Controlled company